HYB Stock Overview
A med-tech company, provides high-tech and medical products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HYB from our risk checks.
HOYA Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥109.20 |
| 52 Week High | JP¥123.05 |
| 52 Week Low | JP¥87.36 |
| Beta | 0.66 |
| 11 Month Change | -0.59% |
| 3 Month Change | -5.58% |
| 1 Year Change | 1.68% |
| 33 Year Change | -2.54% |
| 5 Year Change | 67.66% |
| Change since IPO | 835.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| HYB | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.7% | 3.7% | 0.09% |
| 1Y | 1.7% | 4.1% | 3.1% |
Return vs Industry: HYB underperformed the German Medical Equipment industry which returned 4.1% over the past year.
Return vs Market: HYB underperformed the German Market which returned 3.1% over the past year.
Price Volatility
| HYB volatility | |
|---|---|
| HYB Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: HYB has not had significant price volatility in the past 3 months.
Volatility Over Time: HYB's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 35,702 | Eiichiro Ikeda | www.hoya.com |
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
HOYA Corporation Fundamentals Summary
| HYB fundamental statistics | |
|---|---|
| Market cap | €37.99b |
| Earnings (TTM) | €1.05b |
| Revenue (TTM) | €4.43b |
36.1x
P/E Ratio8.6x
P/S RatioIs HYB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYB income statement (TTM) | |
|---|---|
| Revenue | JP¥762.61b |
| Cost of Revenue | JP¥340.92b |
| Gross Profit | JP¥421.69b |
| Other Expenses | JP¥240.32b |
| Earnings | JP¥181.38b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 01, 2024
| Earnings per share (EPS) | 518.22 |
| Gross Margin | 55.30% |
| Net Profit Margin | 23.78% |
| Debt/Equity Ratio | 0.3% |
How did HYB perform over the long term?
See historical performance and comparison